CA
NZ
UK
AU
IND
US
…
BioLargo, Inc. invents, develops, and commercializes various platform technologies in the United States. The company's technologies solve challenging environmental problems comprising per- and polyfluoroalkyl substances (PFAS) water contamination; advanced water and wastewater treatment; industrial odor and volatile organic compounds control, air quality control, and infection control; and myriad environmental remediation. It provides full-service environmental engineering, battery energy storage, and advanced antimicrobial medical device platforms. BioLargo, Inc. is based in Westminster, California.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | -15.19M | -4.35M | -4.65M | -5.13M | -6.89M |
| Minority interest | 3.41M | 1.95M | 1.14M | 0.66M | -0.19M |
| Net income | -11.78M | -2.40M | -3.50M | -4.47M | -7.08M |
| Selling general administrative | 11.63M | 9.15M | 8.06M | 6.73M | 6.17M |
| Gross profit | 3.41M | 7.85M | 6.15M | 2.86M | 1.10M |
| Reconciled depreciation | 0.41M | 0.26M | 0.27M | 0.04M | 0.02M |
| Ebit | - | - | - | -5.13M | -6.37M |
| Ebitda | - | - | - | -5.03M | -6.64M |
| Operating income | -14.84M | -4.30M | -4.16M | -5.12M | -6.32M |
| Other operating expenses | - | - | - | - | -0.06M |
| Interest expense | 0.54M | 0.07M | 0.09M | 0.05M | 0.23M |
| Interest income | 0.20M | 0.04M | - | - | - |
| Net interest income | -0.34M | -0.14M | -0.09M | -0.05M | -0.23M |
| Total revenue | 7.76M | 17.78M | 12.23M | 5.88M | 2.53M |
| Total operating expenses | 22.60M | 22.08M | 16.39M | 11.00M | 8.85M |
| Cost of revenue | 4.36M | 9.93M | 6.08M | 3.03M | 1.43M |
| Total other income expense net | -0.01M | 0.10M | -0.39M | 0.04M | -0.34M |
| Net income from continuing ops | -15.19M | -4.35M | -4.65M | -5.13M | -6.89M |
| Net income applicable to common shares | - | - | - | - | -7.08M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 8.31M | 10.51M | 8.21M | 4.86M | 3.02M |
| Intangible assets | 0.03M | 0.03M | 0.03M | 0.03M | - |
| Other current assets | 0.31M | 0.09M | 0.06M | 0.12M | 0.09M |
| Total liab | 6.79M | 4.46M | 4.00M | 2.85M | 2.09M |
| Total stockholder equity | 1.53M | 6.06M | 4.20M | 4.88M | 4.65M |
| Other current liab | 0.19M | 0.09M | 0.12M | 0.18M | 0.17M |
| Common stock | - | - | - | - | 0.17M |
| Capital stock | 0.21M | 0.20M | 0.20M | 0.19M | 0.17M |
| Retained earnings | -161.28M | -149.50M | -147.10M | -143.59M | -139.12M |
| Other assets | - | - | - | - | 0.66M |
| Cash | 3.88M | 3.55M | 3.54M | 1.85M | 0.96M |
| Total current liabilities | 5.06M | 2.65M | 2.71M | 1.58M | 1.37M |
| Short long term debt | 1.48M | 0.55M | 0.30M | 0.10M | 0.31M |
| Other stockholder equity | - | - | - | - | -0.12M |
| Property plant equipment | - | - | - | 1.15M | 0.51M |
| Total current assets | 5.11M | 7.14M | 6.36M | 3.15M | 1.80M |
| Long term investments | 0.00M | 0.01M | 0.02M | 0.03M | 0.05M |
| Net tangible assets | - | - | - | 4.88M | 4.65M |
| Net receivables | 0.61M | 3.17M | 2.61M | 1.06M | 0.51M |
| Long term debt | 0.60M | 0.53M | 0.29M | 0.50M | 0.37M |
| Inventory | 0.31M | 0.33M | 0.15M | 0.12M | 0.24M |
| Accounts payable | 1.65M | 1.07M | 1.35M | 0.90M | 0.50M |
| Non currrent assets other | - | - | - | - | 0.07M |
| Non current assets total | 3.20M | 3.38M | 1.84M | 1.71M | 1.22M |
| Capital lease obligations | 1.43M | 1.48M | 1.11M | 0.87M | 0.45M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | -1.32M | -0.44M | -0.27M | -0.03M |
| Change to liabilities | - | - | - | 0.00M | 0.22M |
| Total cashflows from investing activities | - | - | - | - | -0.03M |
| Net borrowings | 1.28M | 0.85M | 0.04M | 0.07M | -0.86M |
| Total cash from financing activities | 8.22M | 4.44M | 4.51M | 3.96M | 4.23M |
| Change to operating activities | - | - | - | 0.02M | 0.02M |
| Net income | -11.78M | -2.40M | -3.50M | -4.47M | -7.08M |
| Change in cash | 0.34M | 0.01M | 1.77M | 0.89M | 0.25M |
| Begin period cash flow | 3.55M | 3.54M | 1.27M | 0.96M | 0.72M |
| End period cash flow | 3.88M | 3.55M | 3.02M | 1.85M | 0.96M |
| Total cash from operating activities | -8.30M | -3.21M | -2.32M | -2.76M | -3.94M |
| Issuance of capital stock | 5.04M | 2.65M | 4.45M | 3.84M | 4.93M |
| Depreciation | 0.41M | 0.26M | 0.20M | 0.04M | 0.02M |
| Change to inventory | 0.02M | -0.18M | -0.07M | -0.04M | 0.04M |
| Change to account receivables | -1.81M | -0.57M | -0.67M | -0.55M | -0.03M |
| Other cashflows from financing activities | - | - | - | - | 0.05M |
| Change to netincome | - | - | - | - | 2.75M |
| Capital expenditures | 0.05M | 1.24M | 0.44M | 0.27M | 0.02M |
| Change in working capital | -1.00M | -1.54M | -0.38M | -0.25M | 0.25M |
| Stock based compensation | 2.96M | 2.06M | 1.89M | 2.07M | 1.87M |
| Other non cash items | 0.62M | 0.33M | 0.45M | 0.31M | 0.50M |
| Free cash flow | -8.34M | -4.44M | -2.76M | -3.03M | -3.97M |
Sector: Basic Materials Industry: Specialty Chemicals
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| BLGO BioLargo Inc |
-0.00 1.43% |
0.07 | - | 13.57 | 7.25 | 18.68 | 8.78 | -10.33 |
| LIN Linde plc Ordinary Shares |
1.09 0.21% |
508.65 | 33.77 | 28.90 | 6.56 | 5.42 | 7.03 | 18.92 |
| AIQUY Air Liquide SA ADR |
-0.21 0.54% |
38.89 | 30.69 | 24.81 | 4.70 | 4.10 | 4.36 | 15.61 |
| AIQUF L'Air Liquide S.A |
-0.00 0.00% |
196.44 | 29.78 | 22.68 | 4.54 | 3.98 | 4.50 | 15.90 |
| SHW Sherwin-Williams Co |
-9.15 2.73% |
326.01 | 33.33 | 27.40 | 3.38 | 20.60 | 3.88 | 21.36 |
BioLargo, Inc. invents, develops, and commercializes various platform technologies in the United States. The company's technologies solve challenging environmental problems comprising per- and polyfluoroalkyl substances (PFAS) water contamination; advanced water and wastewater treatment; industrial odor and volatile organic compounds control, air quality control, and infection control; and myriad environmental remediation. It provides full-service environmental engineering, battery energy storage, and advanced antimicrobial medical device platforms. BioLargo, Inc. is based in Westminster, California.
14921 Chestnut Street, Westminster, CA, United States, 92683
888 400 2863
44
| Name | Title | Year Born |
|---|---|---|
| Mr. Dennis P. Calvert | Chairman, Pres & CEO | 1963 |
| Mr. Charles K. Dargan II, C.F.A. | Chief Financial Officer | 1955 |
| Mr. Joseph L. Provenzano | Exec. VP of Operations, Corp. Sec. & Director | 1969 |
| Mr. Kenneth Reay Code | Chief Science Officer & Director | 1947 |
| Mr. Steven V. Harrison II | Pres of Clyra Medical Technologies Inc | 1959 |
| Mr. Randall Moore | Pres of BioLargo Engineering, Science & Technologies | NA |
| Dr. Richard Smith | Pres of BioLargo Water | NA |
| Mr. Dennis P. Calvert | Chairman, President & CEO | 1963 |
| Mr. Joseph L. Provenzano | Executive VP of Operations, Corporate Secretary & Director | 1969 |
| Mr. Alex Evans | Director of Corporate Communications | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
+1.59%
Communication Services
+0.05%
Consumer Cyclical
+0.14%
Consumer Defensive
-0.43%
Energy
-0.03%
Financial Services
+0.19%
Financials
-0.35%
Healthcare
+1.05%
Industrials
+0.67%
Real Estate
-0.25%
Technology
+1.31%
Utilities
+0.32%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
Please wait processing your request...